Search

everythinglearnresearchcommunity

for

Search:↓

Transgender and gender-diverse teens need specialized skin and mental health care.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Proper planning and technique in upper-face feminization surgery are crucial to avoid complications and revisions.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Care for gender-dysphoric Veterans can be improved with a consistent, team-based approach.

Female representation in dermatology is stable, but minority representation is low and needs improvement.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Hepatitis B virus alters steroid hormones in male mice, reducing dihydrotestosterone to inhibit viral replication.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

Men see SMP as semi-permanent more than women, but women and younger people are more aware of side effects.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Transgender individuals face more barriers and less autonomy in surgical body modifications compared to cisgender individuals.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Adults with gender dysphoria on hormone treatment often have skin problems like acne, which are common but not always recognized.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Hormonal therapy in adults with gender dysphoria often leads to skin issues like acne, requiring a team of skin and hormone doctors.

Facial feminization surgery helps make facial features more feminine, improving patient satisfaction and safety.

The method can identify minerals in hair from water, and using coconut oil or conditioner can prevent mineral buildup.

Hair steroid measurement is an effective method to diagnose and monitor CAH in developing countries.

Alopecia affects self-confidence, body image, and social interactions, causing distress and requiring better support and awareness.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

Boosting motivation can increase physical activity in women with PCOS.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Minoxidil can help transgender males grow facial hair before starting testosterone therapy.

Videodermoscopy better identifies female hair loss than clinical diagnosis.